Clinical Trial Update: Ticagrelor Versus Cilostazol in Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing ticagrelor to cilostazol for ischemic stroke is currently recruiting, sponsored by Kafrelsheikh University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Cilostazol (Cilostazol)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Ischemic Stroke | Phase 3 | Status: RECRUITING